Briumvi and Ocrevus are two prescription drugs available for multiple sclerosis. Find out how they’re alike and different.

Roche has said it plans to UK price ts latest multiple sclerosis drug Ocrevus in line with its close rival from Novartis.

OCREVUS ZUNOVO prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and OCREVUS ZUNOVOside effects.

Following NICE's rejection of Ocrevus in PPMS, more than 21,000 patients had signed a petition calling for a rethink, and more than 3,000 people raised the issue with their local MP, the MS ...

Roche also introduced Ocrevus Zunovo™, aimed at improving treatment accessibility for multiple sclerosis patients in centers with limited IV infrastructure. 3rd party Ad.

Kesimpta, which is used to treat multiple sclerosis, can cause side effects. Learn about its mild and serious side effects and how to manage them.

Best International Companies to Own: 2025 Edition These companies from various corners of the globe are well positioned for the future.

Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study shows.

The disease, which has no known cure, was advanced enough that it requires periodic OCREVUS infusions to keep the wayward antibodies in check. The Burnetts were dealt a setback earlier this year when ...

Find the latest Halozyme Therapeutics, Inc. (HALO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Enrollment is now complete in two Phase 3 clinical trials testing vidofludimus calcium in adults with relapsing forms of multiple sclerosis.

Find the latest iShares U.S. Aerospace & Defense ETF (ITA) stock quote, history, news and other vital information to help you with your stock trading and investing.